Celldex Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2014
Total Assets: $248.0M
Liabilities Breakdown FY2014
Total Liabilities: $36.4M
Asset Breakdown
Total Assets: $248.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $28.0M | 11.3% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $10.5M | 4.2% |
| Goodwill | $9.0M | 3.6% |
| Intangible Assets | $21.8M | 8.8% |
| Other Assets | $178.7M | 72.0% |
Liabilities Breakdown
Total Liabilities: $36.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.6M | 7.2% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $33.8M | 92.8% |